| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
2,576.8740 | 2,576.8740 | 4,338.8270 | 4,529.1960 | 3,870.9670 |
|
Cost of Revenue
|
-976.0730 | -976.0730 | -1,019.6580 | -1,519.2770 | -1,547.2180 |
|
Gross Profit
|
1,600.8010 | 1,600.8010 | 3,319.1690 | 3,009.9190 | 2,323.7490 |
| Selling, General and Administrative Expenses
|
-2,966.1050 | -2,966.1050 | -1,418.0690 | -887.0360 | -891.6140 |
| Other Income/Expense, Operating
|
0 | 0 | 2.6050 | 0 | 53.8460 |
|
Operating Income/Expenses
|
-2,966.1050 | -2,966.1050 | -1,415.4640 | -887.0360 | -837.7680 |
|
Total Operating Profit/Loss
|
-1,365.3040 | -1,365.3040 | 1,903.7050 | 2,122.8830 | 1,485.9810 |
| Total Net Finance Income/Expense
|
96.0480 | 96.0480 | 9.3500 | 9.2610 | 3.2820 |
| Net Investment Income
|
-414.6530 | -414.6530 | 0 | 0 | -- |
| Irregular Income/Expenses
|
-1,942.2660 | -1,942.2660 | 0 | 0 | -- |
|
Other Income/Expense, Non-Operating
|
0 | 0 | 0.3210 | 0 | 12.6740 |
|
Non-Operating Income/Expenses, Total
|
-2,260.8710 | -2,260.8710 | 9.6710 | 9.2610 | 15.9560 |
|
Pretax Income
|
-3,626.1750 | -3,626.1750 | 1,913.3760 | 2,132.1440 | 1,501.9370 |
|
Provision for Income Tax
|
88.9660 | 88.9660 | -294.1790 | -334.0710 | -222.6900 |
|
Net Income from Continuing Operations
|
-3,537.2090 | -3,537.2090 | 1,619.1970 | 1,798.0730 | 1,279.2470 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-3,537.2090 | -3,537.2090 | 1,619.1970 | 1,798.0730 | 1,279.2470 |
|
Non-Controlling/Minority Interests
|
62.5340 | 62.5340 | 0 | 0 | -- |
|
Net Income after Non-Controlling/Minority Interests
|
-3,474.6750 | -3,474.6750 | 1,619.1970 | 1,798.0730 | 1,279.2470 |
|
Net Income Available to Common Stockholders
|
-3,474.6750 | -3,474.6750 | 1,619.1970 | 1,798.0730 | 1,279.2470 |
|
Diluted Net Income Available to Common Stockholders
|
-3,474.6750 | -3,474.6750 | 1,619.1970 | 1,798.0730 | 1,279.2470 |
| Basic EPS
|
-0.14 | -0.14 | 0.07 | 0.09 | 0.05 |
| Diluted EPS
|
-0.14 | -0.14 | 0.07 | 0.07 | 0.05 |
|
Basic Weighted Average Shares Outstanding
|
24,353.5100 | 24,353.5100 | 24,625 | 19,625 | 24,625 |
|
Diluted Weighted Average Shares Outstanding
|
24,353.5100 | 24,353.5100 | 24,625 | 24,625 | 24,625 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-3,722.2230 | -3,722.2230 | 1,904.0260 | 2,122.8830 | 1,498.6550 |
|
EBITDA
|
-3,056.6500 | -3,056.6500 | 2,088.6390 | 2,309.0180 | 1,718.6360 |
|
Normalized EBITDA
|
-699.7310 | -699.7310 | 2,088.6390 | 2,309.0180 | 1,718.6360 |
|
Normalized Income
|
-1,190.4490 | -1,190.4490 | 1,619.1970 | 1,798.0730 | 1,279.2470 |
|
Total Unusual Items
|
2,356.9190 | 2,356.9190 | 0 | 0 | 0 |
3/31/2023 - 7/1/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade